# Pahan K: Lipid-lowering drugs. Cell Mol Life Sci. 2006 May;63(10):1165-78. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16568248 # Iglesias P, Diez JJ: New drugs for the treatment of hypercholesterolaemia. Expert Opin Investig Drugs. 2003 Nov;12(11):1777-89. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/14585054 # Shiomi M, Ito T: MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion. Eur J Pharmacol. 2001 Nov 9;431(1):127-31. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11716851 (en)
MTP mediates triglyceride absorption and chylomicron secretion from the intestine and very-low-density lipoprotein (VLDL) secretion from the liver by linking lipid molecules with apolipoprotein B (apoB). Inhibition of MTP reduces the level of all apoB-containing lipoproteins, including LDL. (en)